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Abstract
Although pheochromocytoma occurs in 1% of patients with von Recklinghausen's disease,
composite tumors in this syndrome are much rarer, with isolated case reports in the literature.
Most gastrointestinal stromal tumors (GISTs) are solitary and sporadic. Multiple GISTs however,
are associated with clinical syndromes particularly von Recklinghausen's disease. We believe this is
the first report of composite adrenal pheochromocytoma and multiple GISTs occurring in an 82
year old woman with neurofibromatosis type 1 (NF1), manifested by clitoral and subcutaneous
neurofibromas, epilepsy and Lisch nodules. The extreme clitoromegaly raised concerns of
pseudohermaphrodism at presentation.
Introduction
Neurofibromatosis type 1 (NF1) is a heterogeneous, dom-
inantly inherited disorder associated with a large number
of different neoplasms, both benign and malignant. Phe-
ochromocytoma occurs in 1% of patients with NF1,
whereas composite tumors of the adrenal medulla are
much rarer. By definition, a composite tumor consists of
pheochromocytoma with neuroblastoma, ganglioneu-
roblastoma or ganglioneuroma. Both cell lines, the chro-
maffin cells and the symapathetic ganglion cells are of
neural crest origin. Gastrointestinal stromal tumors
(GISTs) are the most common mesenchymal neoplasms
of the gastrointestinal tract and have also been described
in association with NF1. GISTs are immunohistochemi-
cally positive for KIT tyrosine kinase receptor and this
characteristic is also found in the interstitial cells of Cajal,
the pacemaker cells regulating autonomic motor activity.
It is postulated that GISTs originate from a multipotential
precursor cells, which differentiate to an interstitial cell of
Cajal phenotype. Neurofibromas of the clitoris have been
reported infrequently. It represents a differential diagnosis
that needs to be considered in pseudohermaphrodism.
NF1 has been associated, albeit rarely, with composite
ganglioneuroma-ganglioneuroma of the adrenal medulla,
multifocal gastric GISTs and neurofibroma of the clitoris,
but we believe this is the first case report whereby all these
disorders occur in the same patient with NF1.
Case report
An 82-year old widow and mother of three with neurofi-
bromatosis was hospitalized following a seizure due to
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non-compliance of anticonvulsant medication Her epi-
lepsy had been previously well controlled on phenytoin
300 mg daily. Cranial computed tomography (CT)
revealed an old left frontal cerebral infarct. The patient's
other past history included mild aortic stenosis, fractured
left neck of femur and iron deficiency anemia. Gastros-
copy and colonoscopy were performed 3 years previously,
when she was investigated for melena and no obvious
cause found. Glibenclamide 5 mg tds had been com-
menced by her general practitioner for symptomatic gly-
cosuria. She was on no other medication.
During this admission, the patient developed a gastroin-
testinal pseudo-obstruction, which was managed conserv-
atively. It was during the investigation of her constipation
and progressive abdominal distension that clitoromegaly
was noted on examination and a 2.5 cm left adrenal mass
found on abdominal CT.
The patient gave a history of clitoral enlargement from
birth and recalls clitoral reduction surgery being offered
and declined at 4-years of age. She developed numerous
subcutaneous nodules at 16-years of age and cutaneous
neurofibroma was confirmed on biopsy of the skin nod-
ule at that time. There was a family history of neurofi-
bromatosis, which afflicted both her maternal
grandmother and great-grandmother, and the patient's
own youngest daughter.
Given the association of neurofibromatosis and pheo-
chromocytoma, the patient was questioned regarding par-
oxysmal symptoms of palpitations, headaches, sweats,
flushing or visual disturbance, but these were absent. On
examination she was normotensive with a postural drop
from 135/60 mmHg to 110/60 mmHg. The pulse rate was
80 and regular and there was an audible, soft, aortic sten-
otic murmur. Widespread cutaneous neurofibromas and
café-au-lait patches were noted. Clitoromegaly was
present with the clitoris measuring 10 × 4 × 4 cm. The vis-
ual fields and fundi were normal although Lisch nodules
were present on the left iris. The patient had bilateral
sensineural hearing loss but no other neurological deficits
were detected.
Biochemical investigations confirmed elevated 24-hour
urinary catecholamine excretion 6 days post admission:
A: Neurofibroma of the clitoris Figure 1
A: Neurofibroma of the clitoris. B: Clitoromegaly.
Figure 1A: Neurofibroma of the clitoris. Figure  1B:  Clitoromegaly. International Seminars in Surgical Oncology 2006, 3:11 http://www.issoonline.com/content/3/1/11
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adrenaline 232 nmol/day (reference interval <120 nmol/
day), noradrenaline 465 nmol/day (ref. <600); and 24 hr
urinary creatinine 4.6 mmol/day (ref. 5.0–16.0). A repeat
24 hr urinary catecholamine three days later also con-
firmed persisting elevation of urinary adrenaline of 149
nmol/day with urinary creatinine of 4.4 mmol/day. Uri-
nary excretion of cortisol was 530 nmol/day (ref. <590).
The patient was biochemically euthyroid with free thyrox-
ine of 13 pmol/L (ref. 9–19) and TSH 3.15 mU/L (ref.
0.30–4.00). Prolactin was 380 mU/L (ref. <420) and she
was normocalcemic, total plasma calcium corrected to
albumin of 40 g/L was 2.47 mmol/L (ref. 2.25–2.60) and
ionised calcium 1.18 mmol/L (ref. 1.12–1.32) adjusted to
pH of 7.4. The serum sex hormone profile revealed testo-
sterone 3.1 nmol/L (ref. <3.5), estradiol 110 pmol/L (ref.
40–130), free androgen index 2.3 (ref. 1–5), DHEA-sul-
phate <0.2 μmol/L (ref. 0.4–2.4), and androstenedione
4.4 nmol/L (ref. 1.6–9.3). Her serum 17-hydroxy proges-
terone was mildly elevated at 2.3 nmol/L (ref. 0.3–1.8)
but this was felt to be of no clinical significance. Cytoge-
netic assessment of peripheral blood revealed a normal
female karyotype.
Given the persistently elevated urinary adrenaline excre-
tion, the CT finding of a 2.5 cm left adrenal tumor was
likely to be functional and this was confirmed using 123I-
MetaIodoBenzyl Guanidine (MIBG) scintigraphy. The
patient was prepared for surgery with phenoxybenzamine
30 mg bd one week pre-operatively with propranolol 40
mg bd added the day prior to surgery. Laparoscopic left
adrenalectomy was undertaken, but this was converted to
an open adrenalectomy due to technical difficulties. Dur-
ing this procedure, approximately ten nodules measuring
between 3 and 5 mm were noted on the serosal surface of
the stomach, one of which was biopsied. Inspection of the
rest of the intra-abdominal viscera was unremarkable.
Core biopsies of the enlarged clitoris were taken. The post-
operative course was uneventful and the patient made an
excellent recovery. Repeat urinary catecholamine excre-
tion prior to discharge was normal.
At two-month follow-up after her adrenalectomy, a clito-
rectomy was performed when a painful ulcer developed
on the clitoris.
Pathological findings
Gastric serosal nodule
Macroscopically, the biopsy consisted of an irregular piece
of firm pinkish tan tissue measuring 6 × 5 × 4 mm. Micro-
scopically, there was a lobulated tumor composed of
elongated uniform spindled cells separated by collagen-
ous stroma. The nuclei were arranged in palisades and
there was no cytological atypia and no mitoses were
present. Small foci of tumor extended into the adjacent
smooth muscle. Immunohistochemistry showed strong
and diffuse staining for c-kit (CD117) and CD34. There
was also focal staining for desmin and smooth muscle
actin. There was no staining with S100. The findings were
consistent with a small gastrointestinal stromal tumor
(GIST).
Clitoral biopsy and clitorectomy
The biopsy consisted of a core of soft, whitish grey tissue
measuring 9-x-7x-1.5 mm and the entire tumor consisted
of a skin covered polypoid mass measuring approximately
90 × 40 mm. There was a large kidney-shaped ulcerated
area with well defined whitish margins measuring 43 × 30
mm. Microscopically there were small circumscribed nests
of neural type structures reminiscent of sensory Meissne-
rian corpuscles separated by slightly myxoid stroma con-
taining numerous mast cells. Focally, there was a diffuse
architectural pattern of ill-defined fascicles of cytologi-
cally uniform spindle cells with abundant fibrillary
matrix. Immunohistochemistry showed S100 positivity.
Histological diagnosis was a clitoral neurofibroma.
Left adrenal tumour
The left adrenal gland measured 48 × 25 × 50 mm and
weighed 11 grams. Bulging above the surface was a nodule
measuring 20 × 20 × 13 mm, which was variegated grey-
yellow-orange on the cut surface. A 6 mm greyish nodule
was found within the adjacent fatty tissue. Microscopi-
cally, the majority of the tumour (70%) showed typical
features of a pheochromocytoma, with discrete nests of
tumour cells separated by delicate fibro-vascular septa.
These cells were of large with conspicuous granular cyto-
plasm and showed pleomorphism, many cells having dis-
tinct nucleoli. Mitotic figures were not seen and there was
no necrosis. The cells extended through the capsule
focally into the peri-adrenal fat. No vascular invasion was
seen. In a few areas the tumour cells were more widely
separated by thick bands of collagen. The second compo-
nent of the tumour (30%) showed features of ganglione-
uroma, with large mature ganglion-type cells with large
nuclei, central eosinophilic nucleoli and abundant cyto-
plasm embedded within a fibrillary neural meshwork
containing cytologically uniform spindle-shaped cells. No
primitive neuroblastic elements were seen. The two
tumour components were well demarcated in some areas,
but focally appeared admixed.
Immunohistochemistry showed no staining of the
tumour elements with the proliferation marker Ki-67 or
p53 protein. Positive staining for S100 protein was identi-
fied in the sustentacular cells within normal adrenal
medulla and in the phechromocytoma, as well as in the
ganglion cells of the ganglioneuroma. The adrenal
tumour was therefore a mixed pheochromocytoma/gan-
glioneuroma or composite pheochromocytoma.International Seminars in Surgical Oncology 2006, 3:11 http://www.issoonline.com/content/3/1/11
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The nodule noted adjacent to the main adrenal swelling
consisted of an enlarged ganglion including expanded
and distorted nerve fibres. The appearances suggested
focal involvement by neurofibroma.
Discussion
Neurofibromatosis type 1 (NF1) is one of the most com-
mon dominantly inherited disorders, with a birth inci-
dence of 1 in 3000 [1]. The classic description given by the
pathologist von Recklinghausen more than a century ago
corresponds well with the most common clinical picture
[2]. The National Institutes of Health Consensus State-
ment [3] outlined seven diagnostic criteria for NF1 and
two or more criteria need to be present in order to make a
diagnosis. These criteria include: 6 or more café-au-lait
macules (size >5 mm in pre-pubertal patients and size >15
mm in post-pubertal patients); 2 or more neurofibromas
or 1 or more plexiform neurofibromas; axillary or
inguinal freckling; 2 or more Lisch nodules; optic gliomas;
specific osseous dysplastic lesions; or a first-degree relative
with NF1 diagnosed with the above criteria.
Expression of NF1 is highly variable. Patients with this
disorder have an increased incidence of both benign and
malignant tumours. This was shown in an investigation of
70 adult NF1 patients in Sweden [1]. Malignant tumours
were reported four times as often in the NF1 group than
in the general population. Of the NF1 group, 24% had
developed malignant tumours (16% carcinoma, 7% sar-
coma, 1% melanoma) and 17% had developed benign
tumours (7% GIST, 6% pheochromocytoma, 3% ade-
noma and 1% meningioma). Pheochromocytomas
(Pheo) are well recognised in the setting of NF1 and said
to be 10 times more common than the general population
[4]. NF1 is found in 5–25% of patients with Pheo [4],
whereas the overall incidence of Pheo in NF1 is 1% [5].
Composite adrenal medullary tumours, on the other
hand, are very rare. In an analysis from the National Can-
cer Institute of 120 adrenal and extra-adrenal Pheos, only
four had a composite phenotype, making an overall inci-
dence of 3% [7]. A review by Moore and Biggs [8] found
only 13 cases of composite pheochromocytoma-gangli-
oneuroma (pheo-GN) reported in the literature. Of these,
only three reports found composite Pheo-GN occurring in
the setting of NF1 [6,9,11]. Our case report represents the
fourth such reported occurrence. In addition, an adrenal
ganglioneuroma and a contralateral Pheo in a patient
with NF1 has been reported [10].
Bolande [12] was the first to propose the concept of neu-
rocristopathies or tumours originating from neural crest-
derived cells. These tumours of neural crest origin are
composed of various combinations of adrenomedullary
or extra-adrenal chromaffin cells, neuroblasts or sympa-
thetic ganglion cells of varying stages of differentiation,
either benign or malignant. Pheo, paraganglioma, GN,
neuroblastoma and neurofibroma all represent such neu-
rocristopathies.
Sympathogonia derived from certain neural crest cells dif-
ferentiate into neuroblasts and pheochromoblasts. These
neural crest-derived cells migrate ventrally and differenti-
ate to give rise to the cellular components of the sympa-
thetic ganglia and the adrenal medulla. Any migration
disturbance or maldevelopment of the neural crest might
result in the development of composite tumours. As these
Neurofibroma of clitoris showing a growth pattern resem- bling Meissner bodies (H&E, original magnification × 250) Figure 3
Neurofibroma of clitoris showing a growth pattern resem-
bling Meissner bodies (H&E, original magnification × 250).
Gastric gastrointestinal stromal tumour (GIST) showing fas- cicles of uniform spindle cells (A, H&E original magnification  × 250) and with c-kit staining of tumour cells compared to  absent staining in adjacent smooth muscle at upper left (B, c- kit original magnification ×100) Figure 2
Gastric gastrointestinal stromal tumour (GIST) showing fas-
cicles of uniform spindle cells (A, H&E original magnification 
× 250) and with c-kit staining of tumour cells compared to 
absent staining in adjacent smooth muscle at upper left (B, c-
kit original magnification ×100).International Seminars in Surgical Oncology 2006, 3:11 http://www.issoonline.com/content/3/1/11
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cell populations have similar derivation one might expect
composite adrenal medullary tumours to be more com-
mon than what is apparent from the literature and this
may represent under-reporting or under-recognition of
this condition.
NF1 affects the gastrointestinal tract in 10–25% of cases
[15] and it does so in four principle forms: stromal
tumours, neuronal hyperplasia, ganglioneuromatosis and
endocrine tumours of the duodenum and periampullary
regions. Acute or recurrent gastrointestinal haemorrhage
may occur in up to 40% of these patients [16]. Gastroin-
testinal stromal tumours (GISTs) are mesenchymal
tumours of the gastrointestinal tract, which do not have
any of the identifying features indicating an origin from a
specific connective tissue cell. They differ from smooth
muscle tumours both immunophenotypically and molec-
ularly. Recently ultrastructural similarities have been
found between GIST cells and the interstitial cell of Cajal
(a gastrointestinal pacemaker cell) [13] and furthermore
there are immunohistochemical similarities with both
expressing KIT tyrosine kinase receptor. It has been sug-
gested that GISTs may originate from stem cells that differ-
entiate towards a pacemaker cell and smooth muscle cell.
GISTs may express a number of different phenotypes,
which has resulted in a multitude of acronyms used to
describe them [14]. Myoid cell types have been called
smooth muscle GISTs (smGIST), neural cell types called
gastrointestinal autonomic nerve tumours (GANT), Cajal
cell types called gastrointestinal pacemaker cell tumours
(GIPACT) and mixed cell types (mixed GIST). The biolog-
ical behaviour of GISTs has been difficult to predict. Mul-
tivariate analysis of survival data in 1004 GISTs has shown
tumour size and location, mitotic rate and age to be
important prognostic factors [17]. However, no method
or combination of methods has proven to be reliable in
determining malignancy in all cases.
Genitourinary neurofibromas are rare and clitoral
involvement in NF1 has been reported infrequently. How-
ever, when it occurs, clitoromegaly is often the presenting
sign. In many cases it is congenital. In a study of 236 fam-
ilies with NF1, four patients had clitoral involvement and
in three, involvement was limited to the clitoris [18]. A
review of the literature by Sulphen [18] found 26 patients
with NF1 and clitoral involvement.
This case report illustrates the heterogeneity of NF1 with
the concomitant presentation of three rare manifestations
of this fascinating disorder, namely composite pheo-GN
of the adrenal medulla, multiple gastric GIST and neurofi-
broma of the clitoris. To our knowledge this is the first
time such a case has been reported in the literature.
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